242 related articles for article (PubMed ID: 16988277)
1. The cryptococcal enzyme inositol phosphosphingolipid-phospholipase C confers resistance to the antifungal effects of macrophages and promotes fungal dissemination to the central nervous system.
Shea JM; Kechichian TB; Luberto C; Del Poeta M
Infect Immun; 2006 Oct; 74(10):5977-88. PubMed ID: 16988277
[TBL] [Abstract][Full Text] [Related]
2. Inositol phosphosphingolipid phospholipase C1 regulates plasma membrane ATPase (Pma1) stability in Cryptococcus neoformans.
Farnoud AM; Mor V; Singh A; Del Poeta M
FEBS Lett; 2014 Nov; 588(21):3932-8. PubMed ID: 25240197
[TBL] [Abstract][Full Text] [Related]
3. Characterization of inositol phospho-sphingolipid-phospholipase C 1 (Isc1) in Cryptococcus neoformans reveals unique biochemical features.
Henry J; Guillotte A; Luberto C; Del Poeta M
FEBS Lett; 2011 Feb; 585(4):635-40. PubMed ID: 21256847
[TBL] [Abstract][Full Text] [Related]
4. Inositol Metabolism Regulates Capsule Structure and Virulence in the Human Pathogen Cryptococcus neoformans.
Wang Y; Wear M; Kohli G; Vij R; Giamberardino C; Shah A; Toffaletti DL; Yu CA; Perfect JR; Casadevall A; Xue C
mBio; 2021 Dec; 12(6):e0279021. PubMed ID: 34724824
[TBL] [Abstract][Full Text] [Related]
5. Role of extracellular phospholipases and mononuclear phagocytes in dissemination of cryptococcosis in a murine model.
Santangelo R; Zoellner H; Sorrell T; Wilson C; Donald C; Djordjevic J; Shounan Y; Wright L
Infect Immun; 2004 Apr; 72(4):2229-39. PubMed ID: 15039347
[TBL] [Abstract][Full Text] [Related]
6. Glucosylceramide synthase is an essential regulator of pathogenicity of Cryptococcus neoformans.
Rittershaus PC; Kechichian TB; Allegood JC; Merrill AH; Hennig M; Luberto C; Del Poeta M
J Clin Invest; 2006 Jun; 116(6):1651-9. PubMed ID: 16741577
[TBL] [Abstract][Full Text] [Related]
7. Depletion of alveolar macrophages decreases the dissemination of a glucosylceramide-deficient mutant of Cryptococcus neoformans in immunodeficient mice.
Kechichian TB; Shea J; Del Poeta M
Infect Immun; 2007 Oct; 75(10):4792-8. PubMed ID: 17664261
[TBL] [Abstract][Full Text] [Related]
8. Methylation of glycosylated sphingolipid modulates membrane lipid topography and pathogenicity of Cryptococcus neoformans.
Singh A; Wang H; Silva LC; Na C; Prieto M; Futerman AH; Luberto C; Del Poeta M
Cell Microbiol; 2012 Apr; 14(4):500-16. PubMed ID: 22151739
[TBL] [Abstract][Full Text] [Related]
9. Cell wall targeting of laccase of Cryptococcus neoformans during infection of mice.
Waterman SR; Hacham M; Panepinto J; Hu G; Shin S; Williamson PR
Infect Immun; 2007 Feb; 75(2):714-22. PubMed ID: 17101662
[TBL] [Abstract][Full Text] [Related]
10. Fbp1-mediated ubiquitin-proteasome pathway controls Cryptococcus neoformans virulence by regulating fungal intracellular growth in macrophages.
Liu TB; Xue C
Infect Immun; 2014 Feb; 82(2):557-68. PubMed ID: 24478071
[TBL] [Abstract][Full Text] [Related]
11. X-linked immunodeficient mice exhibit enhanced susceptibility to Cryptococcus neoformans Infection.
Szymczak WA; Davis MJ; Lundy SK; Dufaud C; Olszewski M; Pirofski LA
mBio; 2013 Jul; 4(4):. PubMed ID: 23820392
[TBL] [Abstract][Full Text] [Related]
12. Identification of App1 as a regulator of phagocytosis and virulence of Cryptococcus neoformans.
Luberto C; Martinez-Mariño B; Taraskiewicz D; Bolaños B; Chitano P; Toffaletti DL; Cox GM; Perfect JR; Hannun YA; Balish E; Del Poeta M
J Clin Invest; 2003 Oct; 112(7):1080-94. PubMed ID: 14523045
[TBL] [Abstract][Full Text] [Related]
13. Virulence factors identified by Cryptococcus neoformans mutant screen differentially modulate lung immune responses and brain dissemination.
He X; Lyons DM; Toffaletti DL; Wang F; Qiu Y; Davis MJ; Meister DL; Dayrit JK; Lee A; Osterholzer JJ; Perfect JR; Olszewski MA
Am J Pathol; 2012 Oct; 181(4):1356-66. PubMed ID: 22846723
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic switching in a Cryptococcus neoformans variety gattii strain is associated with changes in virulence and promotes dissemination to the central nervous system.
Jain N; Li L; McFadden DC; Banarjee U; Wang X; Cook E; Fries BC
Infect Immun; 2006 Feb; 74(2):896-903. PubMed ID: 16428732
[TBL] [Abstract][Full Text] [Related]
15. Cryptococcus neoformans urease affects the outcome of intracellular pathogenesis by modulating phagolysosomal pH.
Fu MS; Coelho C; De Leon-Rodriguez CM; Rossi DCP; Camacho E; Jung EH; Kulkarni M; Casadevall A
PLoS Pathog; 2018 Jun; 14(6):e1007144. PubMed ID: 29906292
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of an SKN7 homologue in Cryptococcus neoformans.
Wormley FL; Heinrich G; Miller JL; Perfect JR; Cox GM
Infect Immun; 2005 Aug; 73(8):5022-30. PubMed ID: 16041017
[TBL] [Abstract][Full Text] [Related]
17. An Antivirulence Approach for Preventing Cryptococcus neoformans from Crossing the Blood-Brain Barrier via Novel Natural Product Inhibitors of a Fungal Metalloprotease.
Aaron PA; Vu K; Gelli A
mBio; 2020 Jul; 11(4):. PubMed ID: 32694141
[No Abstract] [Full Text] [Related]
18. Mechanisms of infection by the human fungal pathogen Cryptococcus neoformans.
Sabiiti W; May RC
Future Microbiol; 2012 Nov; 7(11):1297-313. PubMed ID: 23075448
[TBL] [Abstract][Full Text] [Related]
19. Cryptococcus neoformans hyperfilamentous strain is hypervirulent in a murine model of cryptococcal meningoencephalitis.
Feretzaki M; Hardison SE; Wormley FL; Heitman J
PLoS One; 2014; 9(8):e104432. PubMed ID: 25093333
[TBL] [Abstract][Full Text] [Related]
20. Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans.
Cox GM; McDade HC; Chen SC; Tucker SC; Gottfredsson M; Wright LC; Sorrell TC; Leidich SD; Casadevall A; Ghannoum MA; Perfect JR
Mol Microbiol; 2001 Jan; 39(1):166-75. PubMed ID: 11123698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
